Evidence map›Paper›PMID 40150709›Full record

ArticleBioengineering (Basel, Switzerland)2025

Investigating Connectivity Deficits in Alzheimer's Disease Using a Novel 3D Bioprinted Model Designed to Quantify Neurite Outgrowth.

Chloe Whitehouse, Ellie Bravington, Anirudh Patir, Wei Wei, Janet Brownlees, Yufang He, Nicola Corbett

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chloe WhitehouseMSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.
Ellie BravingtonMSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.ORCID 0009-0003-4795-3749
Anirudh PatirMSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.
Wei WeiMSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.ORCID 0000-0002-2945-3543
Janet BrownleesMSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.ORCID 0000-0002-7035-5160
Yufang HeMerck & Co., Inc., Rahway, NJ 07065, USA.
Nicola CorbettMSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we present a novel 3D bioprinted model of the forebrain cortex designed to quantify neurite outgrowth across a hydrogel bridge. To validate this model, we cultured Alzheimer's disease (AD) forebrain cortical populations derived from human iPSCs carrying APP (amyloid precursor protein) mutations (K670M/N671L + V717F). Neurite and synapse formation were significantly impaired in 3D AD mutant cultures compared to controls, but this was not replicated in 2D, highlighting deficits in these traditional 2D cell culture models. To investigate the mechanisms underlying impaired neurite outgrowth in 3D and 2D models of AD, we assessed amyloid-β dysfunction, mitochondrial health, and oxidative stress in both conditions. In the 3D model, APP mutant cultures exhibited reduced mitochondrial membrane potential and fragmented networks, indicating dysfunction and potential cellular energy deficits. Additionally, elevated oxidative stress and proteostasis disruption were identified in the 3D AD models as indicators of cellular damage, which may be limiting neurite extension. Furthermore, transcriptomic (bulk RNA-Seq) analysis revealed distinct differences in gene expression pathways between 2D and 3D models of AD, suggesting alternate underlying mechanisms of disease pathology between the culture conditions. This study demonstrates the functionality of this novel 3D bioprinted model for quantifying neurite connectivity and identifying underlying disease mechanisms.

Indexed as

3D bioprintingAlzheimer’s diseaseiPSC cultureneurite outgrowth

Identifiers

PMID40150709
PMCPMC11939190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.